Featuring perspectives from Dr Harold J Burstein and Dr Joyce O'Shaughnessy, including the following topics:
- Introduction: ODAC — April 30, 2026 (00:00)
- Adjuvant CDK4/6 Inhibitors (13:03)
- Adjuvant Oral Selective Estrogen Receptor Degraders (21:53)
- Premenopausal Patients (30:52)
- Duration of Adjuvant Endocrine Treatment (38:44)
- Genomic Predictors of Chemotherapy Benefit (47:19)
- Neoadjuvant Treatment (55:13)